Published in Am J Surg Pathol on November 01, 2001
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J (2011) 2.97
HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin. Virchows Arch (2016) 2.11
AMACR expression in colorectal cancer is associated with left-sided tumor localization. Virchows Arch (2008) 1.61
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer (2008) 1.41
Defining aggressive prostate cancer using a 12-gene model. Neoplasia (2006) 1.39
Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol (2007) 1.39
alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol (2002) 1.34
Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer (2006) 1.20
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer. Am J Pathol (2004) 1.15
Primary signet ring cell carcinoma of the prostate. Mayo Clin Proc (2010) 1.13
Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs. BMC Cancer (2014) 1.12
Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden. Am J Clin Pathol (2012) 1.05
Alpha-methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies. J Clin Pathol (2003) 1.00
Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium. Virchows Arch (2003) 1.00
Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer. Diagn Pathol (2010) 0.99
NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol (2010) 0.97
α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues. Urology (2011) 0.91
Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. Br J Cancer (2008) 0.89
Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells. Genome Biol (2003) 0.89
HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin. Virchows Arch (2013) 0.89
Computer-aided detection of prostate cancer on tissue sections. Appl Immunohistochem Mol Morphol (2009) 0.87
Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor. Biosensors (Basel) (2012) 0.86
α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC. J Clin Pathol (2014) 0.86
Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma. J Exp Clin Cancer Res (2008) 0.86
Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics. Anal Chim Acta (2006) 0.85
AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas. World J Gastroenterol (2010) 0.85
Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon. PLoS Genet (2009) 0.84
Current early diagnostic biomarkers of prostate cancer. Asian J Androl (2014) 0.81
α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study. Prostate (2011) 0.81
Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues. Biomed Res Int (2013) 0.81
Cancer of unknown primary finally revealed to be a metastatic prostate cancer: a case report. Cancer Res Treat (2009) 0.81
Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors. Virchows Arch (2004) 0.81
Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer. J Transl Med (2009) 0.80
Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study. J Clin Pathol (2006) 0.80
No-match ORESTES explored as tumor markers. Nucleic Acids Res (2009) 0.79
High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer. Int J Clin Exp Med (2015) 0.79
Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch (2006) 0.78
The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens. Virchows Arch (2006) 0.78
Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas. Hum Pathol (2013) 0.77
Near-infrared fluorescent digital pathology for the automation of disease diagnosis and biomarker assessment. Mol Imaging (2015) 0.77
Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study. Appl Immunohistochem Mol Morphol (2012) 0.77
p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers. Iran J Basic Med Sci (2014) 0.77
Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach. Virchows Arch (2012) 0.76
Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate. Prostate (2015) 0.76
Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer. J Cancer (2016) 0.76
Dietary influences on tissue concentrations of phytanic acid and AMACR expression in the benign human prostate. Prostate (2014) 0.75
The expressions of AMACR and iNOS in prostate adenocarcinomas. Pak J Med Sci (2013) 0.75
Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma. Indian J Urol (2008) 0.75
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate. BMC Urol (2016) 0.75
Co-existence of mucin-producing urothelial-type adenocarcinoma of the prostate and inverted papilloma of the bladder. Contemp Oncol (Pozn) (2017) 0.75
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature (2000) 13.45
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 9.09
Smoking in China: findings of the 1996 National Prevalence Survey. JAMA (1999) 8.67
Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science (2000) 8.56
Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science (1997) 8.16
Phytochromes: photosensory perception and signal transduction. Science (1995) 7.91
Receptor specificity of the fibroblast growth factor family. J Biol Chem (1996) 7.58
Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science (1997) 5.40
Air pollution and mortality in Philadelphia, 1974-1988. Am J Epidemiol (1997) 5.35
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol (1997) 5.06
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
The Human Connectome Project: a data acquisition perspective. Neuroimage (2012) 4.64
A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science (1995) 4.64
Activation of PPARgamma coactivator-1 through transcription factor docking. Science (1999) 4.33
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell (1993) 4.15
Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature (1999) 4.13
Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science (2000) 4.12
Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol (1992) 4.02
Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell (1999) 4.02
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Visual acuity and quality of life in patients with cataract in Doumen County, China. Ophthalmology (1999) 3.82
Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem (2000) 3.74
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science (1992) 3.71
Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci U S A (1997) 3.71
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet (2003) 3.66
Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature (1993) 3.65
A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A (1999) 3.63
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol (1983) 3.58
Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet (1998) 3.55
Epigenetic mechanisms of chemical carcinogenesis. Hum Exp Toxicol (2000) 3.51
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest (1985) 3.41
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A (1993) 3.40
Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med (1984) 3.36
Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med (1992) 3.34
Polarity of T cell shape, motility, and sensitivity to antigen. Immunity (1996) 3.33
Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest (1993) 3.28
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 3.27
Proteolysis, proteasomes and antigen presentation. Nature (1992) 3.15
Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med (2000) 3.12
Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature (1995) 3.07
Surveillance of endophthalmitis following cataract surgery in the UK. Eye (Lond) (2004) 3.07
The SPOROCYTELESS gene of Arabidopsis is required for initiation of sporogenesis and encodes a novel nuclear protein. Genes Dev (1999) 3.07
Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med (1995) 2.98
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature (1997) 2.98
rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis (1996) 2.93
New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis (1986) 2.92
Functional neuronavigation combined with intra-operative 3D ultrasound: initial experiences during surgical resections close to eloquent brain areas and future directions in automatic brain shift compensation of preoperative data. Acta Neurochir (Wien) (2007) 2.89
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology (2003) 2.88
Formation of native hepatitis C virus glycoprotein complexes. J Virol (1997) 2.87
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet (1996) 2.87
Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc Natl Acad Sci U S A (1995) 2.83
High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol (2006) 2.80
The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med (2002) 2.78
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology (2009) 2.76
Mapping quantitative trait loci for yield, yield components and morphological traits in an advanced backcross population between Oryza rufipogon and the Oryza sativa cultivar Jefferson. Theor Appl Genet (2003) 2.76
Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol (2001) 2.74
Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA (1997) 2.73
Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol (1984) 2.73
Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol (1996) 2.69
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med (1991) 2.68
Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J Sci Am (2006) 2.68
Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development. Development (1997) 2.66
Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol (1994) 2.64
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet (1999) 2.62
Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
DNA repair is more important than catalase for Salmonella virulence in mice. J Clin Invest (1995) 2.56
Discovering and understanding genes in human DNA sequence using GRAIL. Methods Enzymol (1996) 2.53
Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry (2007) 2.53
Retracted Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science (2001) 2.52
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost (2011) 2.51
C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol (2000) 2.49
On the use of thiol-modifying agents to determine channel topology. Neuropharmacology (1996) 2.47
Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. Proc Natl Acad Sci U S A (1999) 2.44
A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44
Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem (1997) 2.39
Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J Virol (1997) 2.39
Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity (1994) 2.39
Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology (2010) 2.39
p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J (2000) 2.38
Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol (1995) 2.37
Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science (1996) 2.36
Molecular diagnosis of infective endocarditis--a new Duke's criterion. Scand J Infect Dis (2001) 2.36
Pioneer factors, genetic competence, and inductive signaling: programming liver and pancreas progenitors from the endoderm. Cold Spring Harb Symp Quant Biol (2008) 2.34
Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology (2008) 2.33
JNK is required for effector T-cell function but not for T-cell activation. Nature (2000) 2.33
Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med (1989) 2.30
SPA1: a new genetic locus involved in phytochrome A-specific signal transduction. Plant Cell (1998) 2.28
Nuclear emissions during self-nucleated acoustic cavitation. Phys Rev Lett (2006) 2.28
Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol (1994) 2.25
Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science (1996) 2.25
Agriculture. Increased food and ecosystem security via perennial grains. Science (2010) 2.25